 |
Home
Site Map
ENGLISH/
中文
|
 About OP
|
 Key Professional Strengths
|
 News
|
 News Center
|
 Investors
|
 Sustainable Value
|
 加入友霖 |
Product patent
In addition to a variety of new chemical entities, new dosage forms, new formulations, new indications, and new drug combinations, Orient Pharma invested a lot in patent application and gained many important patents. For example, the technical patent application for three-stage capsule filling technology, controlled release of hypnotic agents, sustained delivery of antibiotics, and three layer semi-solid solution filling technology. We have applied for patent approval in Taiwan, Japan, US, EU, and Canada. Patents for other drugs and manufacturing methods are also being applied in many countries.
| No. | Patent Titles |
| 1 | Combination of Alpha-2 Receptor Agonist (Clonidin) and an Anti-Muscarinic Agent (Oxybutynin) for the Treatment of Sialorrhoea |
| 2 | Drug Combinations For The Treatment Of Sialorrhoea |
| 3 | Controlled Release of Hypnotic Agents |
| 4 | Sustained Delivery of Antibiotics |
| 5 | Compositions and Methods for the Transdermal Delivery of Pharmaceutical Compounds |
| 6 | Pravastatin control release tablets |
| 7 | Oral disintegrating tablets containing Zaleplon |
| 8 | Multi-filled capsules and the manufacturing methods |
| 9 | PC-002 stable pharmaceutical combination |
| 10 | Formulations of Transdermal Patch for 48 Hour Delivery |
Patents belonged to others and licensed to Orient Pharma：
| No. | Patentee | Patent Titles |
| 1 | Foundation of National Defense Research & Education | Low side effect pharmaceutical composition containing Isoniazid. |
| 2 | National defense medical center | Heteroannelated Anthraquinone Derivatives And The Synthesis Method Thereof |
| 3 | OPRX | Methods and compositions for inducing apoptosis by stimulating ER stress |
| 4 | Durect | High Viscosity Liquid Controlled Delivery System |
| 5 | Oral Drug Delivery System | |
| 6 | Oral Pharmaceutical Dosage Forms |
